¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sliding filament model"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • additive model
    µ¡¼À¸ðµ¨
  • absolute risk model
    Àý´ëÀ§Çè¸ðÇü
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • compartment model
    ±¸È¹¸ðµ¨
  • compartmentalization model
    ±¸È¹È­¸ðÇü
  • core conductor model
    ÇÙÀüµµÃ¼¸ðÇü
  • demonstration model
    ½Ã¹ü¸ðÇü
  • fluid mosaic model
    À¯µ¿¸ðÀÚÀÌÅ©¸ðµ¨
  • general linear model
    ÀϹݼ±Çü¸ðµ¨
  • gnathostatic model
    ÅθðÇü, ¾ÇŸðÇü
  • health belief model
    °Ç°­¹ÏÀ½¸ðÇü
  • homeostatic model
    Ç׻󼺸ðÇü
  • in-the-ear model
    ±Ó¼Óº¸Ã»±â
  • model
    ¸ðÇü, ¸ðµ¨
  • model population
    ¸ðÇüÀα¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • animal model
    µ¿¹°¸ðÇü
  • atomic model
    ¿øÀÚ¸ðÇü
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • compartment model
    ±¸È¹¸ðµ¨
  • compartmentalization model
    ±¸È¹È­¸ðÇü
  • core conductor model
    ÇÙÀüµµÃ¼¸ðÇü
  • demonstration model
    ½Ã¹ü¸ðÇü
  • fluid mosaic model
    À¯µ¿¸ðÀÚÀÌÅ©¸ðµ¨
  • general linear model
    ÀϹݼ±»ó¸ðµ¨
  • gnathostatic model
    ÅθðÇü, ¾ÇŸðÇü
  • health belief model
    °Ç°­¹ÏÀ½¸ðÇü
  • homeostatic model
    Ç׻󼺸ðÇü
  • in-the-ear model
    ±Í¼ÓÇüº¸Ã»±â
  • linear quadratic model
    ¼±Çü¹æÇü¸ðµ¨, ¼±ÇüÀÌÂ÷ÇÔ¼ö¸ðµ¨
  • model
    ¸ðÇü, ¸ðµ¨
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • glial filament
    ½Å°æ±³ »ç»óü
  • intersynaptic filament
    °áÇÕ°£¹Ì»ç(Ì¿ùê ÊàÚ°Þê).
  • mitochondrial filament
    »ç¸³Ã¼¹Ì¼¼¼¶À¯
  • muscle filament
    ±Ù Çʶó¸àÆ®
  • myosin filament
    ±½Àº±ÙÀ°¹Ì¼¼¼¶À¯
  • terminal filament
    ³¡¹Ì¼¼¼¶À¯
  • thick filament
    ±½ÀºÇʶó¸àÆ®
  • thick filament
    ±½ÀºÇʶó¸àÆ®.
  • thin filament
    ¼¼»ç(á¬Þê)
  • tungsten filament lamp
    ÅÖ½ºÅÙÇʶó¸àÆ®µî.
  • absolute risk model
    Àý´ëÀ§Çè¸ðµ¨
  • atomic model
    ¿øÀÚ¸ðÇü(¡­Ù¼úþ).
  • biopsychological model
    »ýü½É¸®ÇÐÀû ¸ðµ¨
  • bulk phase model
    µ¢¾î¸® À§»ó ¸ðÇü
  • compartmentalization model
    ±¸È¹È­ ¸ðÇü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Campbell model
    Ä·º§ ¸ðµ¨
  • cloverleaf model
    Ŭ·Î¹öÀÙ ¸ðµ¨
  • concerted model
    Çùµ¿(úðÔÒ) ¸ðµ¨
  • CPK model
    CPK ¸ðµ¨
  • crystallographic model
    °áÁ¤(Ì¿ïÜ) ¸ðµ¨
  • Danielli-Davson model
    ´Ù´Ï¿¤¸®-´ëºê¼Õ ¸ðµ¨
  • Danielli-Davson-Robertson model
    "= unit membrane hypothesis, ´Ù´Ï¿¤¸®-´ëºê¼Õ-·Î¹öÆ®¼Õ ¸ðµ¨"
  • distorted bond model
    ¿Ö°î°áÇÕ(èàÍØÌ¿ùê) ¸ðµ¨
  • doughnut model
    µµ¿ì³Ó ¸ðµ¨
  • Dreiding model
    µå¶óÀ̵ù ¸ðµ¨
  • erosion model
    ¹Ì¶õ(Ú¼Õ´) ¸ðµ¨
  • Ferdinand model
    Æä¸£µð³­µå ¸ðµ¨
  • floating receptor model
    ºÎÀ¯ ¼ö¿ëü(Ý©ë´áôé»ô÷) ¸ðµ¨
  • fluid mosaic model
    À¯µ¿(×µÔÑ) ¸ðÀÚ
  • framework model
    °ñ°Ý(ÍéÌ«) ¸ðµ¨
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CPK cell population kinetic [model]; creatine phosphokinase
GHPM general health policy model
GLIM generalized linear interactive model
GLM general linear model
HBM health belief model; hypertonic buffered medium
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
KIF keratin intermediate filament
CIGMA Continuous Infusion of Glucose with Model Assessment
FEM finite element model
FFM Five Factor Model
FLMP Fuzzy Logical Model of Perception
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • model population
    ¸ðÇü Àα¸
  • MSV model

    MTD (ÃÖ´ë ³»¿ë·®

  • nuclear model
    ÇÙ ¸ðÇü
  • plaster matrix

    plaster model

    ¼®°í ¸ðÇü, ±é½ºÇü
  • psychodynamic experiential model
    Á¤½Å ¿ªµ¿Àû °æÇè ¸ðµ¨
  • symmetry model
    ´ëĪÇü, ´ëμ³
  • wave model
    ÆÄÇü
  • working model for bridgework
    °¡°ø ÀÇÄ¡ ÀÛ¾÷ ¸ðÇü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
spermatic filament A spermatozoon, especially the tail of a spermatozoon.
(05 Mar 2000)
intermediate filament <cell biology> A class of cytoplasmic filaments of animal cells so named originally because their diameter (nominally 10 nm) in muscle cells was intermediate between thick and thin filaments. Unlike microfilaments and microtubules, the protein sub units of intermediate filaments show considerable diversity and tissue specificity.
See: cytokeratins, desmin, glial fibrillary acidic protein, neurofilament proteins, nestin and vimentin
(18 Nov 1997)
intermediate filament proteins Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein.
(12 Dec 1998)
thick filament <cell biology> Bipolar myosin II filaments (12-14nm diameter, 1.6m long) found in striated muscle.
Myosin filaments elsewhere are often referred to as thick filaments, although their length may be considerably less. The myosin heads project from the thick filament in a regular fashion. There is a central bare zone without projecting heads, the core being formed from antiparallel arrays of LMM regions of the myosin heavy chains. Thick filaments will self assemble in vitro under the right ionic conditions.
(18 Nov 1997)
thin filament Filaments 7-9nm diameter attached to the Z discs of striated muscle, have opposite polarity in each half sarcomere. Built of F actin with associated tropomyosin and troponin.
(18 Nov 1997)
Z filament The thin zig-zag structure at the Z line of striated muscle fibres to which the actin filament's attach.
(05 Mar 2000)
filament See: thick filaments, thin filaments, intermediate filaments and microfilaments.
(18 Nov 1997)
filament-nonfilament count A differential count of the number of neutrophils showing nuclear division and those showing no such division.
(05 Mar 2000)
filament polymorphonuclear leukocyte Any mature polymorphonuclear leukocyte, especially a neutrophilic leukocyte, in which the lobes of the nucleus are interconnected with a thin strand or filament of chromatin.
(05 Mar 2000)
Adair-Koshland-Nemethy-Filmer model <biochemistry, chemistry> A model to explain the allosteric form of cooperativity; in this model, in the absence of ligands, the protein exists in only one conformation; upon binding, the ligand induces a conformational change that may be transmitted to other subunits.
Synonym: Adair-Koshland-Nemethy-Filmer model, induced fit model.
(05 Mar 2000)
additive model A model in which the combined effect of several factors is the sum of the effects that would be produced by each of the factors in the absence of the others.
(05 Mar 2000)
age-structured model <epidemiology> A mathematical model which take into consideration the division of the host population into different age classes. Such models can used to consider the consequences of such factors as age-dependent infection, morbidity or mortality rates or of age-specific vaccination schedules.
(05 Dec 1998)
animal model Study in a population of laboratory animals that uses conditions of animals analogous to conditions of humans to simulate processes comparable to those that occur in human populations.
(05 Mar 2000)
Bingham model A model representing the flow behaviour of a Bingham plastic, in the idealised case.
(05 Mar 2000)
biomedical model A conceptual model of illness that excludes psychological and social factors and includes only biological factors in an attempt to understand a person's medical illness or disorder.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • role model
    ¿ªÇÒ ¸ðµ¨
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á